In this webinar we will describe and discuss the advantages of imaging non-labeled tumors with robotic ultrasound (without a hand-held probe). We will present a walk thru the workflow and exemplify a couple of data sets. Beyond measuring 3D tumor volume in a high throughput fashion, we will explore the added value of Acoustic Angiography to quantify tumor vascularity. Lastly, we will touch on imaging of the heart to assess potential drug cardiotoxicity.